St John's wort for major depression (Q24241294)

Cochrane Database of Systematic Reviews

Europe PubMed Central

title

St John's wort for major depression (English)

0 references

author

Levente Kriston

series ordinal

3

0 references

Klaus Linde

object named as

Klaus Linde

series ordinal

1

0 references

author name string

Michael M Berner

series ordinal

2

0 references

publication date

8 October 2008

0 references

published in

0 references

cites work

Comparative efficacy and safety of a once-daily dosage of hypericum extract STW3-VI and citalopram in patients with moderate depression: a double-blind, randomised, multicentre, placebo-controlled study

1 reference

12 December 2020

Cognitive Performance Test: A New Approach to Functional Assessment in Alzheimer's Disease

1 reference

12 December 2020

Efficacy and tolerability of hypericum extract WS 5572 versus placebo in mildly to moderately depressed patients. A randomized double-blind multicenter clinical trial

1 reference

12 December 2020

Efficacy of St. John's wort extract WS 5570 in major depression: a double-blind, placebo-controlled trial.

1 reference

12 December 2020

A double-blind randomised trial to investigate three different concentrations of a standardised fresh plant extract obtained from the shoot tips of Hypericum perforatum L

1 reference

12 December 2020

St. John's wort for depression: a meta-analysis of well-defined clinical trials

1 reference

12 December 2020

Effectiveness and tolerance of the hypericum extract LI 160 in comparison with imipramine: randomized double-blind study with 135 outpatients

1 reference

12 December 2020

Effectiveness of St John's wort in major depression: a randomized controlled trial

1 reference

12 December 2020

Antidepressant-like components of Hypericum perforatum extracts: an overview of their pharmacokinetics and metabolism

1 reference

12 December 2020

Hypericum extract LI 160 and fluoxetine in mild to moderate depression: a randomized, placebo-controlled multi-center study in outpatients

1 reference

12 December 2020

Selective Publication of Antidepressant Trials and Its Influence on Apparent Efficacy

1 reference

12 December 2020

Comparison of an extract of hypericum (LI 160) and sertraline in the treatment of depression: a double-blind, randomized pilot study

1 reference

12 December 2020

Biologically active and other chemical constituents of the herb of Hypericum perforatum L.

1 reference

12 December 2020

Treatment of Seasonal Affective Disorder (SAD) with Hypericum Extract

1 reference

12 December 2020

Atypical depression and related illnesses--neurobiological principles for their treatment with Hypericum extract

1 reference

12 December 2020

St John's wort extract (LI 160) in somatoform disorders: results of a placebo-controlled trial

1 reference

12 December 2020

Co-ingestion of herbal medicines and warfarin.

1 reference

12 December 2020

Effect of Hypericum perforatum (St John's wort) in major depressive disorder: a randomized controlled trial

1 reference

12 December 2020

Assessing the quality of reports of randomized clinical trials: is blinding necessary?

1 reference

12 December 2020

Effectiveness and tolerance of the hypericum extract LI 160 compared to maprotiline: a multicenter double-blind study

1 reference

12 December 2020

Hypericum treatment of mild depressions with somatic symptoms.

1 reference

12 December 2020

[St. John's wort extract in the ambulatory therapy of depression. Attention and reaction ability are preserved]

1 reference

12 December 2020

Hyperforin plasma level as a marker of treatment adherence in the National Institutes of Health Hypericum Depression Trial

1 reference

12 December 2020

Equivalence of St John's wort extract (Ze 117) and fluoxetine: a randomized, controlled study in mild-moderate depression.

1 reference

12 December 2020

Efficacy of continuation treatment with hypericum perforatum in depression.

1 reference

12 December 2020

St. John's wort has no effect on pain in polyneuropathy

1 reference

12 December 2020

Hypericum perforatum: a 'modern' herbal antidepressant: pharmacokinetics of active ingredients

1 reference

12 December 2020

Hypericum perforatum versus fluoxetine in the treatment of mild to moderate depression

1 reference

12 December 2020

The Ham D(6) is more homogenous and as sensitive as the Ham D(17).

1 reference

12 December 2020

Placebo-controlled double-blind study examining the effectiveness of an hypericum preparation in 105 mildly depressed patients

1 reference

12 December 2020

Global burden of depressive disorders in the year 2000

1 reference

12 December 2020

Hypericum extract in patients with MDD and reversed vegetative signs: re-analysis from data of a double-blind, randomized trial of hypericum extract, fluoxetine, and placebo

1 reference

12 December 2020

Superior efficacy of St John's wort extract WS 5570 compared to placebo in patients with major depression: a randomized, double-blind, placebo-controlled, multi-center trial [ISRCTN77277298].

1 reference

12 December 2020

The effectiveness of St. John's Wort in major depressive disorder: a naturalistic phase 2 follow-up in which nonresponders were provided alternate medication.

1 reference

12 December 2020

A New Depression Scale Designed to be Sensitive to Change

1 reference

12 December 2020

Efficacy and tolerability of hypericum extract STW3 in long-term treatment with a once-daily dosage in comparison with sertraline

1 reference

12 December 2020

Effects of hypericum extract LI 160 compared with maprotiline on resting EEG and evoked potentials in 24 volunteers

1 reference

12 December 2020

A Double-blind, randomized trial of St John's wort, fluoxetine, and placebo in major depressive disorder

1 reference

12 December 2020

St John's wort for depression: meta-analysis of randomised controlled trials

1 reference

12 December 2020

Hypericum extract versus imipramine or placebo in patients with moderate depression: randomised multicentre study of treatment for eight weeks

1 reference

12 December 2020

St John's Wort for depression

1 reference

12 December 2020

[St. John' Wort (Hypericum perforatum L.)--multicompound preparations versus single substances]

1 reference

12 December 2020

A rating scale for depression

1 reference

12 December 2020

St John's wort for depression--an overview and meta-analysis of randomised clinical trials

1 reference

12 December 2020

Therapy of depressive states with hypericin

1 reference

12 December 2020

Hypericin and pseudohypericin: pharmacokinetics and effects on photosensitivity in humans.

1 reference

12 December 2020

Bias in meta-analysis detected by a simple, graphical test

1 reference

12 December 2020

Acute treatment of moderate to severe depression with hypericum extract WS 5570 (St John's wort): randomised controlled double blind non-inferiority trial versus paroxetine

1 reference

12 December 2020

St. John's Wort, an anti-depressant? A systematic, criteria-based review

1 reference

12 December 2020

Treatment of mild/moderate depressions with Hypericum

1 reference

12 December 2020

A systematic review of newer pharmacotherapies for depression in adults: evidence report summary

1 reference

12 December 2020

Therapeutic effect of follow-up assessments on antidepressant and placebo response rates in antidepressant efficacy trials: meta-analysis

1 reference

12 December 2020

Efficacy and tolerability of St. John's wort extract LI 160 versus imipramine in patients with severe depressive episodes according to ICD-10

1 reference

12 December 2020

Efficacy and tolerability of Hypericum extract STW 3-VI in patients with moderate depression: a double-blind, randomized, placebo-controlled clinical trial

1 reference

12 December 2020

[Clinical practice guidelines for the diagnosis and therapy of depressive disorders in primary care]

1 reference

12 December 2020

St John's wort for depression: a systematic review

1 reference

12 December 2020

Systematic overview of drug interactions with antidepressant medications

1 reference

12 December 2020

The effect of hypericum extract on cardiac conduction as seen in the electrocardiogram compared to that of imipramine

1 reference

12 December 2020

LI 160, an extract of St. John's wort, versus amitriptyline in mildly to moderately depressed outpatients--a controlled 6-week clinical trial

1 reference

12 December 2020

Pharmacokinetics of hypericin and pseudohypericin after oral intake of the hypericum perforatum extract LI 160 in healthy volunteers

1 reference

12 December 2020

Are the clinical effects of homeopathy placebo effects? A meta-analysis of placebo-controlled trials.

1 reference

12 December 2020

A New Italian Pedigree with Early-Onset Alzheimer's Disease

1 reference

12 December 2020

St John's wort: a systematic review of adverse effects and drug interactions for the consultation psychiatrist

1 reference

12 December 2020

Controlled clinical trials of hypericum extracts in depressed patients--an overview

1 reference

12 December 2020

Effects of hypericum extract on the sleep EEG in older volunteers.

1 reference

12 December 2020

Psychostimulants for depression

1 reference

12 December 2020

St. John's wort in mild to moderate depression: the relevance of hyperforin for the clinical efficacy

1 reference

12 December 2020

Explaining heterogeneity in meta-analysis: a comparison of methods.

1 reference

12 December 2020

Clinical significance of hyperforin for the efficacy of Hypericum extracts on depressive disorders of different severities

1 reference

12 December 2020

Hypericum perforatum versus fluoxetine in the treatment of mild to moderate depression: a randomized double-blind trial in a Brazilian sample

1 reference

12 December 2020

Systematic reviews in health care: Investigating and dealing with publication and other biases in meta-analysis

1 reference

12 December 2020

Comparison of St John's wort and imipramine for treating depression: randomised controlled trial

1 reference

12 December 2020

Symptom reduction and suicide risk in patients treated with placebo in antidepressant clinical trials: an analysis of the Food and Drug Administration database

1 reference

12 December 2020

The effect of St John's wort extracts on CYP3A: a systematic review of prospective clinical trials

1 reference

12 December 2020

St John's wort or sertraline? Randomized controlled trial in primary care

1 reference

12 December 2020

Initial severity and antidepressant benefits: a meta-analysis of data submitted to the Food and Drug Administration

1 reference

12 December 2020

Second thoughts about safety of St John's wort

1 reference

12 December 2020

Comparison of Hypericum extract WS 5570 and paroxetine in ongoing treatment after recovery from an episode of moderate to severe depression: results from a randomized multicenter study.

1 reference

12 December 2020

Comparison of equivalence between the St. John's wort extract LoHyp-57 and fluoxetine

1 reference

12 December 2020

Adverse effects of St. John's Wort: a systematic review

1 reference

12 December 2020

[Treatment of depressive symptoms with a high concentration hypericum preparation. A multicenter placebo-controlled double-blind study]

1 reference

12 December 2020

Measuring inconsistency in meta-analyses

1 reference

12 December 2020

St John's wort for depression

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000448.PUB3

7 January 2021

The emperor's new drugs: An analysis of antidepressant medication data submitted to the U.S. Food and Drug Administration

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000448.PUB3

7 January 2021

Pharmacokinetics of Hypericin and Pseudohypericin after Oral Intake of the Hypericum Perforatum Extract LI 160 in Healthy Volunteers

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000448.PUB3

7 January 2021

Adverse Effects of St. John’s Wort

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000448.PUB3

7 January 2021